The Food and Drug Administration’s recent decision to allow certain nicotine pouches to be marketed as posing fewer health risks than cigarettes could potentially lead to the U.S. becoming smoke-free one day, according to one analyst.

The FDA said Tuesday it will let 20 of Swedish Match USA, Inc.’s ZYN nicotine pouch products be marketed to U.S. consumers with the risk modification claim that “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis,” according to the agency’s news release.

“FDA’s review of modified risk products is intended to ensure that adult users have clear, science-based information about the relative harms of tobacco products, so they can make informed choices,” Acting Director of the FDA’s Center for Tobacco Products Bret Koplow said in a statement. “Today’s decision allows these products to be marketed with a modified risk claim that informs adults who smoke about the lower risks associated with these products.”

The FDA’s decision marks “an acknowledgement of reality,” according to Consumer Choice Center Policy Director David Clement.

“It’s an acknowledgment that, obviously, these products are exponentially less risky than spoken cigarettes, and it’s important that smokers trying to quit know that when they buy them,” Clement told the Daily Caller News Foundation. “And so this is a very positive step forward in terms of overall harm reduction, and it’s a big step forward for anyone who cares about accuracy in marketing.” (Read more from “What The FDA’s Latest Ruling Could Mean For Future Of Nicotine Pouches” HERE)